Aller au contenu principal
Retour aux actualités
Article suivant
Article précédent

Posos: The Digital Treatment

Entrepreneurs

-

02/10/2019

Cette page n'est pas disponible en Français

Emmanuel Bilbault (E10) created Posos to provide healthcare professionals with simple, reliable and personalized information on medicines.

Posos is developing an artificial intelligence-based decision support solution, capable of understanding, contextualizing and answering medication-related questions (posology, side effects, associated risks). In other terms: “Our technology allows healthcare professionals to ask questions the way they would ask their colleagues.”

Posos can generate insights about how drugs are prescribed, dispensed and consumed. It unlocks the value of medications data and drives decisions that improve health outcomes. These insights, often buried in unstructured data, are otherwise difficult to get and far too labor-intensive to extract with current tools. “Our expertise is to use the state of the art in natural language processing (NLP) to query a set of biomedical data and answer to any question, no matter the language, grammar, syntax, even spelling mistakes.”


Find out more:
www.posos.fr

Want to read more? Please join ESSEC Alumni for us to be able to bring other contents about ESSEC’s community to you.


Illustration : Emmanuel Bilbault (E10)

Commentaires0

Veuillez vous connecter pour lire ou ajouter un commentaire

Articles suggérés

Cabane, la maille made in France à l’épreuve du marché
Entrepreneurs

Cabane, la maille made in France à l’épreuve du marché

photo de profil d'un membre

Chloé CONSIGNY

09 novembre

Ordalie, l'IA juridique qui vise la souveraineté
Entrepreneurs

Ordalie, l'IA juridique qui vise la souveraineté

photo de profil d'un membre

Chloé CONSIGNY

12 octobre

À Station F, l'incubateur ESSEC x ESSEC Alumni met l'accent sur la vente
Entrepreneurs

À Station F, l'incubateur ESSEC x ESSEC Alumni met l'accent sur la vente

photo de profil d'un membre

Chloé CONSIGNY

14 septembre